Dimension Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch DMTX and buy or sell other stocks, ETFs, and their options commission-free!About DMTX
Dimension Therapeutics, Inc. engages in the development of novel treatments for rare diseases. Its activities include discoveries and development of therapeutic products for people living with rare diseases associated wit the liver and caused by genetic mutations.
CEOAnnalisa Mary Jenkins, PhD
CEOAnnalisa Mary Jenkins, PhD
Employees—
Employees—
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2013
Founded2013
Employees—
Employees—
DMTX Key Statistics
Market cap149.99M
Market cap149.99M
Price-Earnings ratio-2.67
Price-Earnings ratio-2.67
Dividend yield—
Dividend yield—
Average volume28.04K
Average volume28.04K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$6.10
52 Week high$6.10
52 Week low$1.05
52 Week low$1.05
Stock Snapshot
As of today, Dimension Therapeutics(DMTX) shares are valued at $5.95. The company's market cap stands at 149.99M, with a P/E ratio of -2.67.
On 2025-12-11, Dimension Therapeutics(DMTX) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 28.04K.
The stock's 52-week range extends from a low of $1.05 to a high of $6.10.
The stock's 52-week range extends from a low of $1.05 to a high of $6.10.